"The ISH’s main objectives are to promote and encourage the advancement of scientific knowledge in all aspects of research and its application to prevention and management of heart disease and stroke in hypertension and related cardiovascular diseases around the world."
Corporate Members: Astra Zeneca Boehringer-Ingelheim MSD Novartis
(http://www.ish-world.com/default.aspx?CorporateMembers; accessed 10/2/06)
The 2006 Scientific Meeting of the ISH in Japan is sponsored by: Pfizer Novartis Takeda Sankyo Astellas Boehringer-Ingelheim Daiichi Pharmaceutical Co.
(http://www.congre.co.jp/ish2006/main_isp.html; accessed 10/2/06)